140 related articles for article (PubMed ID: 3890574)
1. Evaluation of sporontocidal compounds using Plasmodium falciparum gametocytes produced in vitro.
Teklehaimanot A; Nguyen-Dinh P; Collins WE; Barber AM; Campbell CC
Am J Trop Med Hyg; 1985 May; 34(3):429-34. PubMed ID: 3890574
[TBL] [Abstract][Full Text] [Related]
2. Plasmodium falciparum: effect of chloroquine, halofantrine and pyrimethamine on the infectivity of gametocytes for Anopheles stephensi mosquitoes.
Chutmongkonkul M; Maier WA; Seitz HM
Ann Trop Med Parasitol; 1992 Apr; 86(2):103-10. PubMed ID: 1417200
[TBL] [Abstract][Full Text] [Related]
3. Gametocytocidal and sporontocidal effects of primaquine and of sulfadiazine with pyrimethamine in a chloroquine-resistant strain of Plasmodium falciparum.
Rieckmann KH; McNamara JV; Frischer H; Stockert TA; Carson PE; Powell RD
Bull World Health Organ; 1968; 38(4):625-32. PubMed ID: 4876731
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of pyrimethamine, cycloguanil, and other antimalarial drugs against African isolates and clones of Plasmodium falciparum.
Basco LK; Ramiliarisoa O; Le Bras J
Am J Trop Med Hyg; 1994 Feb; 50(2):193-9. PubMed ID: 8116812
[TBL] [Abstract][Full Text] [Related]
5. Molecular epidemiology of malaria in Yaounde, Cameroon. VI. Sequence variations in the Plasmodium falciparum dihydrofolate reductase-thymidylate synthase gene and in vitro resistance to pyrimethamine and cycloguanil.
Basco LK; Ringwald P
Am J Trop Med Hyg; 2000 Feb; 62(2):271-6. PubMed ID: 10813484
[TBL] [Abstract][Full Text] [Related]
6. A new model for testing gametocytocidal effects of some antimalarial drugs on Plasmodium falciparum in vitro.
Chutmongkonkul M; Maier WA; Seitz HM
Ann Trop Med Parasitol; 1992 Jun; 86(3):207-15. PubMed ID: 1449270
[TBL] [Abstract][Full Text] [Related]
7. [In vitro sensitivity of Plasmodium falciparum to anti-folinic agents (trimethoprim, pyrimethamine, cycloguanil): a study of 29 African strains].
Basco LK; Le Bras J
Bull Soc Pathol Exot; 1997; 90(2):90-3. PubMed ID: 9289260
[TBL] [Abstract][Full Text] [Related]
8. The activity of proguanil and its metabolites, cycloguanil and p-chlorophenylbiguanide, against Plasmodium falciparum in vitro.
Watkins WM; Sixsmith DG; Chulay JD
Ann Trop Med Parasitol; 1984 Jun; 78(3):273-8. PubMed ID: 6385887
[TBL] [Abstract][Full Text] [Related]
9. Analogues of N-benzyloxydihydrotriazines: in vitro antimalarial activity against Plasmodium falciparum.
Childs GE; Lambros C
Ann Trop Med Parasitol; 1986 Apr; 80(2):177-81. PubMed ID: 3530157
[TBL] [Abstract][Full Text] [Related]
10. Gametocytocidal activity of pyronaridine and DNA topoisomerase II inhibitors against multidrug-resistant Plasmodium falciparum in vitro.
Chavalitshewinkoon-Petmitr P; Pongvilairat G; Auparakkitanon S; Wilairat P
Parasitol Int; 2000 Feb; 48(4):275-80. PubMed ID: 10725690
[TBL] [Abstract][Full Text] [Related]
11. Genome comparison of progressively drug resistant Plasmodium falciparum lines derived from drug sensitive clone.
Toteja R; Nair L; Bhasin V
Mem Inst Oswaldo Cruz; 2001 Apr; 96(3):427-33. PubMed ID: 11313656
[TBL] [Abstract][Full Text] [Related]
12. The transmission-blocking effects of antimalarial drugs revisited: fitness costs and sporontocidal effects of artesunate and sulfadoxine-pyrimethamine.
Villa M; Buysse M; Berthomieu A; Rivero A
Int J Parasitol; 2021 Mar; 51(4):279-289. PubMed ID: 33508331
[TBL] [Abstract][Full Text] [Related]
13. In vitro selection of Plasmodium falciparum lines resistant to dihydrofolate-reductase inhibitors and cross resistance studies.
Bhasin VK; Nair L
Jpn J Med Sci Biol; 1996 Feb; 49(1):1-14. PubMed ID: 8799803
[TBL] [Abstract][Full Text] [Related]
14. In vitro antimalarial activity of tetrahydrofolate dehydrogenase inhibitors.
Sixsmith DG; Watkins WM; Chulay JD; Spencer HC
Am J Trop Med Hyg; 1984 Sep; 33(5):772-6. PubMed ID: 6385738
[TBL] [Abstract][Full Text] [Related]
15. Concomitant resistance to pyrimethamine and cycloguanil of chloroquine-resistant falciparum malaria from East Africa: an in vitro study of 12 isolates.
Schapira A
Trans R Soc Trop Med Hyg; 1984; 78(3):359-62. PubMed ID: 6380024
[TBL] [Abstract][Full Text] [Related]
16. Molecular basis of differential resistance to cycloguanil and pyrimethamine in Plasmodium falciparum malaria.
Peterson DS; Milhous WK; Wellems TE
Proc Natl Acad Sci U S A; 1990 Apr; 87(8):3018-22. PubMed ID: 2183222
[TBL] [Abstract][Full Text] [Related]
17. Amino acids in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum involved in cycloguanil resistance differ from those involved in pyrimethamine resistance.
Foote SJ; Galatis D; Cowman AF
Proc Natl Acad Sci U S A; 1990 Apr; 87(8):3014-7. PubMed ID: 2183221
[TBL] [Abstract][Full Text] [Related]
18. Prevention of sporogony of Plasmodium falciparum and P. berghei in Anopheles stephensi mosquitoes by transmission-blocking antimalarials.
Coleman RE; Nath AK; Schneider I; Song GH; Klein TA; Milhous WK
Am J Trop Med Hyg; 1994 May; 50(5):646-53. PubMed ID: 8203716
[TBL] [Abstract][Full Text] [Related]
19. Sustained efficacy of artesunate-sulfadoxine-pyrimethamine against Plasmodium falciparum in Yemen and a renewed call for an adjunct single dose primaquine to clear gametocytes.
Atroosh WM; Al-Mekhlafi HM; Snounou G; Al-Jasari A; Sady H; Nasr NA; Lau YL; Surin J
Malar J; 2016 May; 15(1):295. PubMed ID: 27234587
[TBL] [Abstract][Full Text] [Related]
20. Gametocytocidal and sporontocidal activity of some standard antimalarials on P. berghei (NK 65) infection M. natalensis.
Rastogi M; Pal NL; Sen AB
Indian J Malariol; 1989 Mar; 26(1):9-18. PubMed ID: 2680637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
